BioSpace News Archive

The conference call will be available via phone and webcast.

Moleculin Biotech today announced that 14 qualified cancer clinics have requested to participate in its clinical trial to study Annamycin for the treatment of relapsed or refractory acute myeloid leukemia.

AstraZeneca today announced new results of a study that investigated respiratory syncytial virus (RSV) hospitalization risk and costs during the 2014-2016 RSV seasons compared to the 2012-2014 RSV seasons.

The Cap-Score is projected to improve pregnancy rates and save couples time and money.

India Globalization Capital provides compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model.

Novel technology discovered at University of Melbourne has the potential to transform the management of cancer.

Plasticell, the biotechnology company specialising in stem cell screening and cell therapy development, has entered into a collaboration with GSK to use its combinatorial stem cell screening technology, CombiCult, to optimise the directed differentiation of induced pluripotent stem cells (iPSCs) to specific blood cell lineages for use by GSK in its therapeutic research.

Ms. Fish was most recently the Chief Human Resources Officer for Marlin Equity Partners, a private equity firm.

Mutabilis announces its selection by the European ENABLE project (European Gram-negative Antibacterial Engine), which aims to improve the development of antibiotics against infections caused by multiresistant Gram-negative bacteria.

Revance Therapeutics, today announced that the company will release third quarter 2017 financial results on Thursday, November 2, 2017 after the close of market.